Neuromuscular Disorders

Featured Article

Differentiating Multiple Sclerosis Mimics on MRI

Differentiating Multiple Sclerosis Mimics on MRI

A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.

Latest

Pediatric Multiple Sclerosis Linked to Epstein-Barr, Herpes Simplex Virus Exposure

Pediatric Multiple Sclerosis Linked to Epstein-Barr, Herpes Simplex Virus Exposure

Increased risk of pediatric multiple sclerosis was observed in patients with prior exposure to EBV, HSV-1, and vitamin D deficiency.

In Relapsing MS, Fatigue, Limb Problems May Signal Risk for Disease Conversion

In Relapsing MS, Fatigue, Limb Problems May Signal Risk for Disease Conversion

In older patients with relapsing multiple sclerosis, patient-reported fatigue and problems with lower extremities may signal conversion to secondary progressive disease.

No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate

No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate

More participants achieved clinical NEDA with DMF than placebo over 2 years in the integrated analysis.

Ocrelizumab Approved for Progressive, Relapsing Multiple Sclerosis

Ocrelizumab Approved for Progressive, Relapsing Multiple Sclerosis

The biannual infusion is approved for the treatment of adults with relapsing and progressive forms of multiple sclerosis.

In Multiple Sclerosis, Anxiety May Signal Depression

In Multiple Sclerosis, Anxiety May Signal Depression

A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.

RENEW Trial: Promising Results for Optic Neuritis Treatment

RENEW Trial: Promising Results for Optic Neuritis Treatment

Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.

FDA Approves Duchenne Muscular Dystrophy Drug

FDA Approves Duchenne Muscular Dystrophy Drug

Emflaza is approved for the treatment of Duchenne muscular dystrophy regardless of genetic etiology.

ICER Report: New Multiple Sclerosis Drugs More Effective, But Safety Concerns Abound

ICER Report: New Multiple Sclerosis Drugs More Effective, But Safety Concerns Abound

Several new multiple sclerosis drugs, including natalizumab, may be more effective at reducing relapses but still come with serious safety concerns.

Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant

Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant

Five years after treatment, nearly 70% of patients with relapsing-remitting multiple sclerosis showed no signs of disease progression.

MicroRNA in Multiple Sclerosis May Signify Disease Progression

MicroRNA in Multiple Sclerosis May Signify Disease Progression

Several microRNA were found to be associated with lesion volume and brain atrophy in multiple sclerosis.

Sign Up for Free e-newsletters